Skip to main content
Toggle navigation
Login
Home
Tweets by 2022 Canadian Cardiovascular Congress
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
In Person Event
Livestream
On Demand
Ticketed Event
Browse by Presentation Number
Browse by Presentation Number
Type here to filter the list
Sort by
#
Sort by
Title
P001
B-MODE ULTRASOUND-GUIDED LOW-LEVEL FOCUSED-ULTRASOUND SONODYNAMIC THERAPY OF NEOINTIMAL HYPERPLASIA USING PHOTOFRIN-LOADED MICROBUBBLES
Favorite
P002
CHARACTERIZING AN ARRHYTHMIA-RELATED TITIN MUTATION USING PATIENT STEM CELL-DERIVED ATRIAL CARDIOMYOCYTES
Favorite
P003
CORRELATION OF CELL SENESCENCE WITH THE AGE-ASSOCIATED INCREASE IN VWF EXPRESSION
Favorite
P004
EFFECT OF GLYCOSAMINOGLYCANS ON OPENING ANGLE OF INTACT & CROSSLINKED AORTAS
Favorite
P005
EFFECTS OF ENVELOPES ON CIED POCKET HEALING: A HEAD-TO-HEAD PRECLINICAL EVALUATION
Favorite
P006
EICOSAPENTAENOIC ACID (EPA) DECREASES CYTOKINE RELEASE AND EXPRESSION OF INFLAMMATORY AND PRO-THROMBOTIC PROTEINS IN BRAIN VASCULAR ENDOTHELIUM
Favorite
P007
ENDOTHELIAL COLONY-FORMING CELL-DERIVED EXTRACELLULAR VESICLES AND CARDIAC REPAIR AFTER MYOCARDIAL INFARCTION
Favorite
P008
EXTRACELLULAR VESICLES FROM HUMAN HEART EXPLANT-DERIVED CELLS ATTENUATE ACTIVATION OF THE NLRP3 INFLAMMASOME IN MACROPHAGES
Favorite
P009
HIGH-INTENSITY STATINS COMBINED WITH EICOSAPENTAENOIC ACID (EPA) IMPROVES ENDOTHELIAL FUNCTION DURING EXPOSURE TO OXIDIZED LDL
Favorite
P010
IMMUNE ANALYSIS OF TISSUE ENGINEERED PORCINE AORTIC VALVE LEAFLETS AFTER ALPHA-GALACTOSE CLEAVAGE
Favorite
P011
IMMUNOENGINEERING APPLICATION OF MXENE FOR PREVENTION OF TRANSPLANT VASCULOPATHY
Favorite
P012
INCREASED EICOSAPENTAENOIC ACID TO ARACHIDONIC ACID (EPA/AA) RATIO IN BRAIN ENDOTHELIAL CELLS ASSOCIATED WITH REDUCED EXPRESSION OF NEUTROPHIL DEGRANULATION PROTEINS DURING INFLAMMATION
Favorite
P013
INTESTINAL ADAPTATION TO SHORT-TERM, EXTREME FAT CONSUMPTION ALTERS TRIGLCYERIDE-RICH LIPOPROTEIN SECRETION AND INTESTINAL LIPID HANDLING IN MALE AND FEMALE MICE
Favorite
P014
KETONE ESTER THERAPY REDUCES CARDIAC INFLAMMATION AND CARDIAC DYSFUNCTION IN SEPSIS
Favorite
P015
LARGE ANIMAL MODEL OF DONATION AFTER CIRCULATORY DEATH AND NORMOTHERMIC REGIONAL PERFUSION FOR CARDIAC ASSESSMENT
Favorite
P016
MITRAL VALVE CHORDAE TENDINEAE DEVELOP INDEPENDENTLY FROM LEAFLET TISSUE DURING FETAL DEVELOPMENT
Favorite
P017
NOVEL SYNTHETIC HSP90 INHIBITOR FORMULATION IMPROVES CARDIOPROTECTION IN RAT AND HUMAN IN VITRO ISCHEMIA/REPERFUSION CELL MODEL
Favorite
P018
ON-THE-SPOT NANOSPRAY PEPTIDE-GOLD FORMULATION FOR MYOCARDIAL INFARCTION TREATMENT
Favorite
P019
PRE-CLINICAL EVALUATION OF A THIRD GENERATION ABSORBABLE ANTIBACTERIAL ENVELOPE
Favorite
P020
PROTOCOL DEVELOPMENT FOR SINGLE-NUCLEUS RNA SEQUENCING OF HUMAN HEART TISSUE
Favorite
P021
REMODELING OF BOVINE DESCENDING AORTA AND AORTIC VALVE DURING PREGNANCY ARE NOT REVERSED POSTPARTUM
Favorite
P022
SIRT3 PREVENTS DOXORUBICIN INDUCED DILATED CARDIOMYOPATHY VIA REGULATION OF MITOCHONDRIAL PROTEIN ACETYLATION: INVESTIGATING METABOLIC DYSFUNCTION AS A RESULT OF ALTERATIONS TO CARDIAC LIPIDS
Favorite
P023
TARGETING TUMOR NECROSIS FACTOR (TNF) IN ATRIAL STRETCH-DEPENDENT ADVERSE ATRIAL REMODELING AND VALVULAR ATRIAL FIBRILLATION IN A MOUSE MODEL OF AORTIC REGURGITATION
Favorite
P024
TREADMILL STRESS TEST VENTILATORY PATTERN USING A WEARABLE DEVICE AS AN ADDITIONAL MARKER FOR CV DISEASE
Favorite
P025
A COMPARATIVE ANALYSIS OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION BETWEEN CANADA AND THE UNITED STATES FROM THE NORTH AMERICAN COVID-19 STEMI REGISTRY
Favorite
P026
ARE BEST PRACTICE GUIDELINES INFORMING WITHDRAWAL OF LIFE SUSTAINING THERAPY FOLLOWED AFTER CARDIAC ARREST?
Favorite
P027
COMPARING DUAL ANTIPLATELET THERAPY STRATEGIES POST-ACUTE CORONARY SYNDROME: NETWORK META-ANALYSIS
Favorite
P028
EARLY SUCCESS AND COST-EFFECTIVENESS OF A SOCIAL MEDIA CAMPAIGN TO REDUCE PRE-HOSPITAL DELAYS IN PATIENTS WITH POSSIBLE ACUTE CORONARY SYNDROME
Favorite
P029
ESTIMATED PULSE WAVE VELOCITY INDEPENDETLY PREDICTS SURVIVAL-TO-DISCHARGE IN PATIENTS REQUIRING EXTRACORPOREAL MEMBRANE OXYGENATION: A SINGLE-CENTRE RETROSPECTIVE COHORT STUDY
Favorite
P030
SAFETY AND FEASIBILITY OF VERY EARLY DISCHARGE IN LOW-RISK PATIENTS WITH STEMI AFTER PRIMARY PCI
Favorite
P031
THE EFFECT OF BETA BLOCKAGE IN PATIENTS FOLLOWING ACUTE CORONARY SYNDROME - STRATIFIED ACCORDING TO LEFT VENTRICULAR EJECTION FRACTION.
Favorite
P032
THE RETURN OF SUBCLAVIAN CANNULATION IN THE CRITICAL CARE SETTING: A WESTERN CRITICAL CARE EXPERIENCE
Favorite
P033
A COMPARISON OF SYNTHETIC DATA GENERATION AND FEDERATED ANALYSIS FOR PERFORMING AN INTERNATIONAL ASSESSMENT OF GENDER EFFECTS ON CARDIOVASCULAR HEALTH
Favorite
P034
EFFECT OF TAFAMIDIS ON GLOBAL LONGITUDINAL STRAIN USING A CORRECTION METHOD IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS
Favorite
P035
EVALUATION OF THE REAL-WORLD PLACE OF THE ICOSAPENT ETHYL (IPE) FOR THE TREATMENT OF PATIENTS WITH HYPERTRIGLYCERIDEMIA REQUIRING INVASIVE CORONARY ANGIOGRAM
Favorite
P036
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IN CANADA
Favorite
P037
INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-7 AS A MARKER OF CARDIAC REVERSE REMODELING WITH EMPAGLIFLOZIN: A SECONDARY ANALYSIS OF THE EMPA-HEART CARDIOLINK-6 RANDOMIZED CONTROLLED TRIAL
Favorite
P038
LEFT VENTRICULAR MASS PREDICTS CARDIAC REVERSE REMODELING IN PATIENTS TREATED WITH EMPAGLIFLOZIN: AN EXPLORATORY SUB-ANALYSIS OF THE EMPA-HEART CARDIOLINK-6 RANDOMIZED CONTROLLED TRIAL
Favorite
P039
ROLE OF SEX AND GENDER IN DEVELOPMENT OF METABOLIC SYNDROME: A PROSPECTIVE COHORT STUDY
Favorite
P040
TEMPORAL TRENDS OF THE PREVALENCE OF ISCHEMIA WITH NON-OBSTRUCTIVE CORONARY ARTERY DISEASE (INOCA) IN ALBERTA, CANADA
Favorite
P041
THE IMPACT OF STATIN ON POST-OPERATIVE ATRIAL FIBRILLATION AFTER DISCHARGE FROM CARDIAC SURGERY: SECONDARY ANALYSIS OF THE SEARCH-AF CARDIOLINK-1 RANDOMIZED TRIAL
Favorite
P042
THE NON-INVASIVE ASSESSMENT OF PERIPHERAL MICROVASCULAR AND ENDOTHELIAL FUNCTION IN WOMEN WITH NON-OBSTRUCTIVE CORONARY ARTERY DISEASE
Favorite
P043
ADULT CONGENITAL HEART DISEASE HEALTH SERVICES IN CANADA-WHERE HAVE WE COME IN THE PAST 15 YEARS
Favorite
P044
DETERMINING RESEARCH PRIORITIES WITH TEEN AND ADULT CONGENITAL HEART DISEASE PATIENTS: A MIXED METHODS STUDY
Favorite
P047
KAWASAKI DISEASE, MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN AND COVID-19 IN A TERTIARY PEDIATRIC HOSPITAL IN MONTREAL, CANADA
Favorite
P050
SURGICAL OUTCOMES IN INFANTS WITH MAJOR CONGENITAL HEART DISEASE EXPOSED TO MATERNAL DIABETES IN UTERO
Favorite
P052
THE IMPACT OF THE COVID-19 PANDEMIC RESTRICTIONS ON THE PROVISION OF ACHD CARE ACROSS CANADA
Favorite
P053
ANGIOGRAPHIC PREDICTORS OF CTO PCI SUCCESS: HOW TO GUIDE DECISION MAKING BEYOND THE J-CTO SCORE
Favorite
P054
LINKS BETWEEN CORONARY MICROVASCULAR DYSFUNCTION AND EVIDENCE OF HEART FAILURE WITH PRESERVED EJECTIVE FRACTION
Favorite
P055
ONE-YEAR OUTCOMES IN PATIENTS WHO UNDERWENT CORONARY INTRAVASCULAR SHOCKWAVE LITHOTRIPSY FOR HIGHLY-CALCIFIED CORONARY LESIONS
Favorite
P056
USE OF A DIGITAL APPLICATION TO OPTIMIZE THE CLINICAL TRAJECTORY OF PATIENTS IN A TAVI PROGRAM
Favorite
P057
WHAT HS-TROPONIN LEVEL BEST CORRELATES WITH A PROGNOSTICALLY SIGNIFICANT CK-MB INCREASE POST-ELECTIVE PERCUTANEOUS INTERVENTION?
Favorite
P058
AWARENESS OF LIPID GUIDELINE RECOMMENDATIONS FOR HIGH-RISK PATIENTS AMONGST PRIMARY CARE PHYSICIANS IN CANADA
Favorite
P059
COMPETENCY-BASED CARDIOLOGY TRAINING: A SIMPLE APPROACH TO IMPROVE SUPERVISOR COMPLETION OF EPAS
Favorite
P060
EVALUATION OF WRITTEN MEDICATION EDUCATIONAL RESOURCES FOR PEOPLE LIVING WITH HEART FAILURE
Favorite
P061
EXAMINING THE ASSOCIATION BETWEEN DOMAINS OF FRAILTY AND 6-MONTH CHANGES IN HEALTH-RELATED QUALITY OF LIFE, LIVING STATUS, AND TREATMENT DECISIONAL REGRET AMONG OLDER PATIENTS REFERRED FOR CARDIAC SURGERY
Favorite
P062
SUPPORTIVE CARDIOLOGY: A QUALITY IMPROVEMENT PROJECT TO MEET THE GAPS IN LATE-STAGE HEART FAILURE CARE
Favorite
P063
SUSTAINED USAGE OF AN APP FOR RISK STRATIFICATION AND OPTIMIZATION OF PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Favorite
P064
ATOMOXETINE FOR SUPPRESSION OF VASOVAGAL SYNCOPE: A CLINICAL CASE SERIES
Favorite
P065
BI-ATRIAL MAPPING AND ELEVATED HEART RATES IDENTIFY ABNORMAL ATRIAL SUBSTRATE IN ATRIAL FIBRILLATION PATIENTS WITHOUT LOW-VOLTAGE AREAS IN THE LEFT ATRIUM
Favorite
P066
CARDIAC IMPLANTABLE ELECTRONIC DEVICE LEAD PERFORATION RATES, MANAGEMENT AND OUTCOMES.
Favorite
P067
CARDIOLOGIST EVALUATION OF ELECTROCARDIOGRAM COLLECTED AT THE WAIST WITH TEXTILE ELECTRODES
Favorite
P068
COMMUNITY-TO-INSTITUTION ATHLETIC CARDIOVASCULAR SCREENING: VALIDATION OF AN ELECTROCARDIOGRAM WORKFLOW MODEL
Favorite
P069
CURRENT DEFINITIONS TO IDENTIFY SUDDEN CARDIAC DEATH AS A CAUSE FOR CARDIAC ARREST ARE INACCURATE: LIMITATIONS OF EMS RECORDS
Favorite
P070
DEACTIVATION OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS AT DISTANCE FOR THE DIGNITY OF DYING (THE 4D STUDY)
Favorite
P071
DETECTION OF CONGENITAL LONG QT SYNDROME WITH ARTIFICIAL INTELLIGENCE
Favorite
P072
DIAGNOSTIC UTILITY OF HOLTER MONITORING IN CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA
Favorite
P073
EFFICACY AND SAFTEY OF SUPRACLAVICULAR AND PECTORALIS NERVE BLOCKS AS PRIMARY PERI-PROCEDURAL ANALGESIA FOR CARDIAC ELECTRONIC DEVICE IMPLANTATION: A PILOT STUDY
Favorite
P074
FEMALE SEX IS NOT ASSOCIATED WITH INCREASED SURVIVAL AFTER NON-TRAUMATIC OUT OF HOSPITAL CARDIAC ARREST: A SYSTEMATIC REVIEW AND META-ANALYSIS
Favorite
P075
LEADLESS PACEMAKER IMPLANT IN PATIENTS REQUIRING CIED EXTRACTION: OUTCOMES BASED UPON TIMING OF EXTRACTION
Favorite
P076
OBJECTIVE CARDIOVASCULAR AUTONOMIC ABNORMALITIES IN POST-ACUTE SEQUELAE OF COVID-19 (PASC): OVERALL AND SEX-BASED PREVALENCE
Favorite
P077
PATIENT PERCEPTIONS AFTER EMERGENCY DEPARTMENT VISITS FOR ATRIAL FIBRILLATION: UNNECESSARY FEAR?
Favorite
P078
PREVALENCE OF UNREPORTED ATRIAL FIBRILLATION IN ELECTROCARDIOGRAMS WITH VENTRICULAR-PACED RHYTHM: A MULTICENTER EXPERIENCE
Favorite
P079
QUANTITATIVE COMPARISON OF ELECTROCARDIOGRAM FROM SKIIN FULLY TEXTILE CHEST BAND AGAINST STANDARD GEL ELECTRODES
Favorite
P080
REAL-WORLD EXPERIENCE ON THE SAFETY AND EFFECTIVENESS OF MICRA TPS IN PATIENTS WITH PRE-EXISTING IN SITU CIEDS
Favorite
P081
RELATIONSHIPS BETWEEN LEFT VENTRICULAR MASS AND QRS DURATION IN HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART DISEASE: A NEW DIAGNOSIS TOOL
Favorite
P082
SAME-DAY DISCHARGE FOLLOWING ATRIAL FIBRILLATION ABLATION PROCEDURE
Favorite
P083
SEX DIFFERENCES IN ATRIAL FIBRILLATION AND ATRIAL STRUCTURAL REMODELLING: INSIGHTS FROM HIGH-RESOLUTION BI-ATRIAL ELECTROANATOMIC MAPPING
Favorite
P084
SIMPLIFIED EKG ONLY METHOD TO ACHIEVE PHYSIOLOGIC PACING.
Favorite
P085
STANDARD VERSUS INTENSIVE MONITORING POST-MYOCARDIAL INFARCTION LOOKING FOR NEW-ONSET ATRIAL FIBRILLATION OR FLUTTER: FINDINGS FROM THE SIMPL-AF TRIAL
Favorite
P086
STROKE RISK AND ORAL ANTICOAGULATION USE WITH EXTENDED CARDIAC MONITORING FOR ATRIAL FIBRILLATION VERSUS USUAL CARE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Favorite
P087
STROKE, DEATH, AND ADHERENCE TO ORAL ANTICOAGULANTS IN AF: A RETROSPECTIVE OBSERVATIONAL STUDY WITH ADHERENCE AS A CONTINUOUS VARIABLE
Favorite
P088
SURVIVAL, VENTRICULAR ARRHYTHMIA, AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR USEFULNESS IN A COHORT OF PATIENTS WITH TOXIC DILATED CARDIOMYOPATHY
Favorite
P089
TEMPORAL TRENDS OVER 13 YEARS IN CARDIAC ELECTRONIC DEVICE INFECTION RATES AND PREVENTION OF ARRHYTHMIA DEVICE INFECTION TRIAL (PADIT) SCORES
Favorite
P090
THE EFFECT OF NURSE PRACTITIONER-LED CARE IN TERTIARY CARE ON HEALTH-RELATED QUALITY OF LIFE IN ADULT PATIENTS WITH ATRIAL FIBRILLATION- RESULTS OF A RANDOMIZED CONTROLLED TRIAL
Favorite
P091
VARIABILITY IN NOAC DOSE ELIGIBILITY AND ADJUSTMENT ACCORDING TO RENAL FORMULAE AND CLINICAL OUTCOMES IN AF PATIENTS WITH AND WITHOUT CKD: INSIGHTS FROM ORBIT AF II
Favorite
P092
WAIST-HIGH COMPRESSION GARMENTS REDUCE ORTHOSTATIC TACHYCARDIA IN PATIENTS WITH POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME IN A COMMUNITY SETTING
Favorite
P093
A PROPENSITY-MATCHED COHORT STUDY TO ASSESS THE EFFECTIVENESS OF A COMMUNITY HOSPITAL BASED HEART FUNCTION CLINIC
Favorite
P094
ADHERENCE TO GUIDELINE-DIRECTED MEDICAL THERAPY AMONG PATIENTS FOLLOWED AT AN AMBULATORY HEART FUNCTION CLINIC
Favorite
P095
AN ASSESSMENT OF GOAL-DIRECTED BEHAVIOURS THAT PROMOTE HEALTH-RELATED QUALITY OF LIFE: A PROOF-OF-CONCEPT STUDY
Favorite
P096
ASSOCIATION OF DURATION AND INTENSITY OF EXERCISE WITH SEVERITY OF PHENOTYPIC EXPRESSION IN HYPERTROPHIC CARDIOMYOPATHY
Favorite
P097
BALLISTOCARDIOGRAPHY TO CHARACTERIZE PULMONARY ARTERY PRESSURE IN ADVANCED HEART FAILURE PATIENTS AND HEALTHY ADULTS
Favorite
P099
CARDIAC RESYNCHRONISATION AND LEFT VENTRICULAR EJECTION FRACTION IMPROVEMENT WITH SINGLE VENTRICULAR PHYSIOLOGICAL PACING LEAD
Favorite
P100
DEVELOPMENT OF A DIAGNOSTIC SCREENING ALGORITHM FOR THE IDENTIFICATION OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY IN HIGH-RISK PATIENT POPULATIONS
Favorite
P101
EARLY DETECTION OF POLYNEUROPATHY IN PATIENTS WITH HEREDITARY TRANSTHYRETIN AMYLOIDOSIS CARDIOMYOPATHY
Favorite
P102
ECHOCARDIOGRAPHIC EVALUATION OF LEFT VENTRICULAR REMODELING AFTER VALSARTAN/SACUBITRIL INITIATION IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION
Favorite
P103
EFFECTIVENESS, SAFETY, AND TOLERABILITY OF SACUBITRIL/VALSARTAN OVER 3 YEARS OF FOLLOW-UP IN CANADIAN PRACTICE: INSIGHTS FROM THE PARTHENON REGISTRY
Favorite
P104
HIGH-INTENSITY INTERVAL TRAINING FOR HEART FAILURE AND POST-HEART TRANSPLANT: A SYSTEMATIC REVIEW AND META-ANALYSIS
Favorite
P105
IMPROVED SURVIVAL WITH ~5 YEARS OF CONTINUOUS TAFAMIDIS TREATMENT AMONG PATIENTS WITH NYHA CLASS III TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Favorite
P106
IS FLAXSEED EQUIVALENT AND/OR SYNERGISTIC WITH ACE INHIBITION IN THE TREATMENT OF CHEMOTHERAPY MEDIATED CARDIOTOXICITY?
Favorite
P107
MEDICAL MANAGEMENT OF HEART FAILURE WITH CONCURRENT DIABETES MELLITUS IN CANADIAN PRIMARY CARE
Favorite
P108
MYOCARDIAL RECOVERY AND SURVIVAL AFTER WEANING OF LEFT VENTRICULAR ASSIST DEVICE THERAPY IN PATIENTS WITH TOXIC AND NON-TOXIC CARDIOMYOPATHIES, A CANADIAN EXPERIENCE
Favorite
P109
PHARMACIST-LED TITRATION CLINIC FOR HFREF MEDICATION : RESULTS FROM ITS FIRST 2 YEARS OF EXISTENCE
Favorite
P110
PREDICTING 1-YEAR MORTALITY IN AMBULATORY HEART FAILURE PATIENTS: EMPIRIC MODELS OUTPERFORM PHYSICIAN INTUITIVE ESTIMATES
Favorite
P111
PREDICTING LONG-TERM SURVIVAL AFTER DE NOVO CARDIOVERTER DEFIBRILLATOR IMPLANTATION FOR PRIMARY PREVENTION
Favorite
P112
PREVALENCE OF ANEMIA IN CARDIAC AMYLOIDOSIS AND ASSOCIATION WITH CLINICAL FACTORS AND OUTCOMES
Favorite
P113
PROGRESSION OF TRICUSPID REGURGITATION AND CLINICAL OUTCOMES IN PATIENTS WITH LONGSTANDING PERSISTENT ATRIAL FIBRILLATION
Favorite
P114
PUMPING IRON: A QUALITY IMPROVEMENT STUDY FOR THE TREATMENT OF IRON DEFICIENCY ANEMIA IN AMBULATORY HEART FAILURE PATIENTS
Favorite
P115
SEVERITY OF LEFT VENTRICULAR DYSFUNCTION IN PATIENTS WITH TACHYCARDIA-INDUCED CARDIOMYOPATHY: IMPACTS ON REMODELING AFTER ATRIAL FLUTTER ABLATION
Favorite
P116
SEX DIFFERENCES IN PULMONARY AND SYSTEMIC VASCULAR FUNCTION AT REST AND DURING EXERCISE IN HEALTHY OLDER ADULTS
Favorite
P117
SINGLE CENTRE COMPARISON OF PATIENTS MANAGED BY A CODE SHOCK TEAM VERSUS STANDARD OF CARE
Favorite
P118
SODIUM RESTRICTION IN PATIENTS WITH HEART FAILURE:A SYSTEMATIC REVIEW AND META-ANALYSIS OFRANDOMIZED CLINICAL TRIALS
Favorite
P119
SODIUM-GLUCOSE TRANSPORT PROTEIN 2 INHIBITOR ELIGIBILITY FOR PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE
Favorite
P120
TIME TO GUIDELINE-DETERMINED MEDICAL THERAPY IN PATIENTS WITH DE NOVO HEART FAILURE: A RETROSPECTIVE POPULATION-BASED STUDY FROM ALBERTA, CANADA
Favorite
P121
UTILITY OF A MEDICAL OPTIMIZATION CLINIC IN HEART FAILURE PATIENTS WITH AN IMPLANTED CARDIAC DEVICE
Favorite
P122
WHY IS HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF) MORE COMMON IN WOMEN THAN MEN? EXPLORING ABNORMALITIES IN PULSITILE ARTERIAL LOAD AS DISTINCT FEATURE OF THE HFPEF SYNDROME IN WOMEN
Favorite
P123
ARTIFICIAL INTELLIGENCE FOR AUTOMATED CALCIUM QUANTIFICATION FROM NON-CONTRAST ENHANCED CT IN PATIENTS WITH DEGENERATIVE AORTIC STENOSIS
Favorite
P124
COMPARISON OF POST-PROCESSING TECHNIQUES FOR OPTIMIZING THE QUALITY OF CARDIAC MAGNETIC RESONANCE T1 MAPPING IMAGES
Favorite
P125
DEEP LEARNING MODELS FOR AUTOMATING ASSESSMENT OF LEFT VENTRICULAR WALL THICKNESS AND DIMENSIONS
Favorite
P126
DIFFERENCES IN RIGHT VENTRICULAR REMODELING AND ITS IMPACT ON SURVIVAL BETWEEN MEN AND WOMEN WITH AORTIC STENOSIS
Favorite
P127
EARLY ADAPTATION OF THE MITRAL VALVE AFTER ST-ELEVATION MYOCARDIAL INFARCTION
Favorite
P128
ENDOTHELIAL PROGENITOR CELLS ENGINEERED TO OVER-EXPRESS ENDOTHELIAL NO-SYNTHASE AND THEIR EFFECT ON ARRHYTHMIC SUBSTRATE AS ASSESSED BY GRAY ZONE ANALYSIS - A SUB-STUDY OF THE ENACT-AMI TRIAL
Favorite
P129
EXPLORATORY IN-CLINIC STUDY EVALUATING FEASIBILITY OF JVP HEIGHT ASSESSMENT BY EARLY PROTOTYPE OF MACHINE VISION ALGORITHM
Favorite
P130
MANAGEMENT AND OUTCOMES OF MITRAL ANNULAR CALCIFICATION THROMBUS: A SYSTEMATIC REVIEW
Favorite
P131
MECHANISTIC CLASSIFICATION AND OUTCOMES OF ISOLATED AORTIC REGURGITATION IN A CONTEMPORARY COHORT OF PATIENTS
Favorite
P132
PATIENTS WITH NON-ISCHEMIC CARDIOMYOPATHY AND MID-WALL STRIAE HAVE SIMILAR OUTCOMES AS PATIENTS WITH ISCHEMIC CARDIOMYOPATHY: A PROPENSITY-MATCHED ANALYSIS
Favorite
P133
PROGNOSTIC VALUE OF EXERCISE RIGHT VENTRICULAR FREE WALL STRAIN IN PATIENTS WITH SICKLE CELL DISEASE
Favorite
P134
SPECKLE TRACKING RV GLOBAL LONGITUDINAL STRAIN FOR PREDICTION OF PULMONARY HYPERTENSION
Favorite
P136
VENTRICULAR-ARTERIAL DECOUPLING IS ASSOCIATED WITH IN-HOSPITAL ADVERSE EVENTS IN NORMOTENSIVE PULMONARY EMNBOLISM
Favorite
P137
A NURSE-DRIVEN, FAMILY-ENGAGED EARLY MOBILITY PROGRAM IN THE CARDIAC INTENSIVE CARE UNIT
Favorite
P138
ATTITUDES AND BELIEFS OF HEALTH CARE PROVIDERS REGARDING THE TREATMENT OF PATIENTS WITH OBESITY IN A TERTIARY CARE INSTITUTION. RESULTS OF A PAN-INSTITUTION SURVEY
Favorite
P139
CARDIAC SURGERY VIRTUAL FOLLOW-UP FOR PATIENTS AT HIGH-RISK FOR HOSPITAL READMISSION: DEVELOPMENT OF AN ENHANCED REMOTE TELEMONITORING CARE PLATFORM
Favorite
P140
FACTORS INFLUENCING PATIENT DECISION AID USE FOR IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR DECISIONS IN THREE CANADIAN ACADEMIC HOSPITALS
Favorite
P141
FOCUS GROUP: IMPROVING THE KNOWLEDGE OF PATIENTS ON WOMEN'S HEART HEALTH SELF-CARE MANAGEMENT
Favorite
P142
IMPLEMENTATION OF AN EARLY MOBILIZATION PROTOCOL TO ACCELERATE RECONDITIONING AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: IDENTIFICATION OF BARRIERS TO STANDARDIZED NURSING PRACTICE
Favorite
P143
INTERSECTIONALITY-BASED REVIEW OF HEART FAILURE TELEHEALTH/ REMOTE MONITORING INTERVENTIONS FOR VULNERABLE POPULATIONS
Favorite
P144
MAGNETIC RESONANCE IMAGING AND CARDIAC IMPLANTABLE ELECTRONIC DEVICES: WHAT YOU NEED TO KNOW
Favorite
P145
MEASURING WITH MEANING: PATIENTS' PERSPECTIVE ON SELF-MONITORING OF BLOOD PRESSURE VIA VIRTUAL VISIT
Favorite
P146
MOVING RIGHT ALONG: INCORPORATING PATIENT-SPECIFIC RISK FACTORS IN POST-CARDIAC SURGERY STERNAL PRECAUTIONS PRESCRIPTIONS
Favorite
P147
RESETTING THE BAR: INCREASING CARDIOVASCULAR REHABILITATION ENROLLMENT IN A TERTIARY CARDIAC CARE SETTING
Favorite
P148
VALIDATION OF THE ESSENTIAL FRAILTY TOOLSET: CAN FRAILTY BE MEASURED IN THE VIRTUAL CLINIC?
Favorite
P149
VIRTUAL PEER-TO-PEER MENTORING FOR ADOLESCENTS WITH CONGENITAL HEART DISEASE: AN IMPLEMENTATION STUDY
Favorite
P150
A POST-ARREST CARE BUNDLE IMPROVES QUALITY OF CARE AND CLINICAL OUTCOMES DURING THE NORMOTHERMIA ERA
Favorite
P151
ANTICOAGULATION FOR ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE STAGES 4 AND 5, NOT ON DIALYSIS
Favorite
P152
CARDIOVASCULAR CARE EXPERIENCES OF PEOPLE EXPERIENCING HOMELESSNESS AND THE FUTURE CO-DESIGN OF A CARE PROGRAM: A COMMUNITY-BASED STUDY IN TORONTO
Favorite
P153
COMPARISON OF RATES AND OUTCOMES OF READMISSIONS TO INDEX VERSUS NON-INDEX HOSPITALS AFTER CARDIAC SURGERY: A NATIONWIDE ANALYSIS
Favorite
P154
COVID-19 RISK IN THE CARDIAC CATHETERIZATION LABORATORY
Favorite
P155
EVALUATING THE IMPACT OF PHARMACY-LED GUIDELINE DIRECTED MEDICAL THERAPY IN A HEART FUNCTION CLINIC
Favorite
P156
IDENTIFYING SOCIAL FACTORS THAT MAY LIMIT EARLY DISCHARGE IN LOW-RISK ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
Favorite
P157
INDIGENOUS SUPPORT SERVICES IN CANADIAN CARDIAC CENTRES
Favorite
P159
ACCESS TO HEALTHCARE, PREVENTIVE LIPID-LOWERING THERAPY, AND CHARACTERISTICS AT PRESENTATION IN A CONTEMPORARY POPULATION OF YOUNG ADULTS WHO GO ON TO DEVELOP PREMATURE CORONARY ARTERY DISEASE
Favorite
P160
BENEFITS OF ICOSAPENT ETHYL IN PATIENTS WITH PRIOR PERIPHERAL ARTERY DISEASE: REDUCE-IT PAD
Favorite
P161
CALCIFIED CAROTID ARTERY ATHEROMA ON STANDARD DENTAL RADIOGRAPHS: A PUBLIC HEALTH OPPORTUNITY FOR CARDIOVASCULAR RISK REDUCTION
Favorite
P162
DEVELOPMENT AND APPLICATION OF A TAXONOMY ON THE BENEFITS OF ORAL ANTICOAGULANT SWITCHING IN ATRIAL FIBRILLATION
Favorite
P163
GENETIC TESTING FOR FAMILIAL HYPERCHOLESTEROLEMIA IN THE PROVINCE OF QUÉBEC: A SINGLE CENTER RETROSPECTIVE COHORT STUDY
Favorite
P164
IMPACT OF DIABETES AND GLUCOSE-LOWERING THERAPY ON POST-OPERATIVE ATRIAL FIBRILLATION AFTER CARDIAC SURGERY: SECONDARY ANALYSIS OF THE SEARCH-AF CARDIOLINK-1 RANDOMIZED CLINICAL TRIAL
Favorite
P165
IMPACT OF OUTCOME DEFINITIONS ON CARDIOVASCULAR RISK PREDICTION IN A CONTEMPORARY PRIMARY PREVENTION POPULATION
Favorite
P166
JUMPSTART-TAVR PILOT: EVALUATION OF AN EARLY MOBILIZATION VIRTUAL EXERCISE MODULE POST TAVR
Favorite
P167
REAL-WORLD OUTCOMES & HEALTH CARE COSTS OF REGION-WIDE COMMUNITY-BASED CARDIAC REHABILITATION
Favorite
P168
REDUCTION IN ISCHEMIC EVENTS, INCLUDING CARDIOVASCULAR MORTALITY, WITH ICOSAPENT ETHYL IN PATIENTS WITH PRIOR MYOCARDIAL INFARCTION: REDUCE-IT PRIOR MI
Favorite
P169
RISK FACTORS AND COMORBIDITIES ASSOCIATED WITH PREMATURE NON-OBSTRUCTIVE CORONARY ARTERY SYNDROMES IN WOMEN
Favorite
P170
SARC-F PREDICTS POOR MOTOR FUNCTION AND PROGNOSIS IN OLDER PATIENTS WITH CARDIOVASCULAR DISEASE WITH COGNITIVE IMPAIRMENT
Favorite
P171
SEX DISPARITIES IN TREATMENT AND CLINICAL OUTCOMES OF FAMILIAL HYPERCHOLESTEROLEMIA
Favorite
P173
THE SOCIAL ROBOTS ARE COMING: HEALTH CARE PROVIDERS' PERSPECTIVES OF SOCIAL ROBOTS AS A FORM OF VIRTUAL CARE IN CARDIOVASCULAR MEDICINE
Favorite
P174
ADDITIVE VALUE OF NT-PROBNP RATIO IN THE MANAGEMENT OF MIXED AORTIC VALVE DISEASE PATIENTS
Favorite
P175
AMI-PONT PROSPECTIVE RANDOMIZED CLINICAL TRIAL FOR ANTEROLATERAL TERRITORY CORONARY ARTERY BYPASS GRAFTING STRATEGIES
Favorite
P177
CANNULATION STRATEGY IMPACTS PERIOPERATIVE SAFETY IN ACUTE TYPE A DISSECTION: CANADIAN MULTICENTRE DATA
Favorite
P178
CONTINUOUS FORMS OF INTRA-OPERATIVE ULTRAFILTRATION ENHANCE RECOVERY AFTER ADULT CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Favorite
P179
CREATING THE IDEAL ARTIFICIAL HEART VALVE
Favorite
P180
DETERMINING THE TRANSLATIONAL POTENTIAL OF HUMAN PERICARDIAL FLUID TO IMPROVE CLINICAL OUTCOMES IN CARDIAC SURGERY
Favorite
P181
DEVELOPMENT OF A HIGH-FIDELITY SIMULATOR TO PREDICT THE RISK OF CORONARY OCCLUSION IN HIGH-RISK VALVE-IN-VALVE PROCEDURES
Favorite
P182
DIRECT ORAL ANTICOAGULANTS VERSUS VITAMIN K ANTAGONISTS IN THE FIRST 3 MONTHS AFTER BIOPROSTHETIC VALVE REPLACEMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS
Favorite
P183
DIRECT ORAL ANTICOAGULATION VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND BIOPROSTHETIC HEART VALVES: A RETROSPECTIVE, REAL WORLD COHORT STUDY
Favorite
P185
EARLY OUTCOMES OF NEOCORD DS1000 TRANSAPICAL OFF-PUMP REPAIR OF SEVERE MITRAL REGURGITATION IN HIGH-RISK PATIENTS: A SINGLE CENTRE CASE SERIES STUDY
Favorite
P186
EDGE-TO-EDGE TECHNIQUE WITH PARTIAL BAND FOR MITRAL VALVE REPAIR COMPARED TO MITRAL REPLACEMENT FOR ISCHEMIC MITRAL REGURGITATION
Favorite
P192
LONG-TERM OUTCOMES OF ISOLATED MECHANICAL VERSUS BIOPROSTHETIC MITRAL VALVE REPLACEMENT IN PROPENSITY MATCHED PATIENTS
Favorite
P193
OUTCOMES OF AXILLARY VS FEMORAL ARTERIAL CANNULATION IN ACUTE TYPE A DISSECTION REPAIR: AN INTERNATIONAL MULTICENTRE STUDY
Favorite
P194
PERCUTANEOUS CORONARY INTERVENTION VERSUS CORONARY ARTERY BYPASS GRAFTING FOR PATIENTS WITH LEFT VENTRICULAR SYSTOLIC DYSFUNCTION: A META-ANALYSIS OF KAPLAN-MEIER DERIVED INDIVIDUAL PATIENT DATA
Favorite
P196
PREDICTORS OF MITRAL VALVE HEMODYNAMICS AFTER MITRAL VALVE REPAIR FOR DEGENERATIVE MITRAL REGURGITATION: A SUBANALYSIS OF THE CAMRA RANDOMIZED TRIAL
Favorite
P198
SURGICAL OR PERCUTANEOUS LEFT ATRIAL APPENDAGE OCCLUSION IN PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED TRIALS
Favorite
P199
THE LIPID PARADOX IN POSTOPERATIVE ATRIAL FIBRILLATION
Favorite
P201
ANGIOTENSIN 1-7 EXERTS PROTECTIVE EFFECTS IN THORACIC AORTIC ANEURYSM BY ATTENUATING SMOOTH MUSCLE CELL PHENOTYPIC SWITCHING
Favorite
P202
DIETARY INTAKE AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH CHRONIC VASCULAR DISEASE IN THE COMPASS TRIAL
Favorite
P203
SEX DIFFERENCES IN ARTERIAL HEMODYNAMICS IN PATIENTS WITH DEGENERATIVE THORACIC AORTIC ANEURYSMS
Favorite
P204
TOTAL ENDOVASCULAR AORTIC ARCH REPAIR
Favorite
P205
TREATMENT IMPLICATIONS OF THE REDUCE-IT RESULTS TO PEOPLE OF SOUTH ASIAN (SA) DESCENT LIVING IN CANADA WITH KNOWN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE(THE REDUCE-IT CANADA SA STUDY)
Favorite
P206
VASCULAR SMOOTH MUSCLE CELL PHENOTYPIC DIFFERENTIATION AND METABOLIC DYSFUNCTION IN THORACIC AORTA ATHEROSCLEROSIS
Favorite
